Overview
| Name | GPT-Rosalind · aliases: GPT-Rosalind |
|---|---|
| Full name | A product name with no expanded form |
| Ambiguous names (not auto-linked) | None |
| Family | Not a family entry. The developer calls it the first model in a life-sciences series with no other members yet |
| Organization | OpenAI |
| Organization type | Big-tech lab |
| Country | United States |
| Model class | Life-sciences reasoning LLM |
| Domain | Text, LLMs & agents |
| First release | · product update Basis: Developer launch announcement source |
| Other milestones | |
| Latest update | † partly verified · product update Basis: Developer update announcement Exits research preview and opens globally to eligible organisations through controlled access, covering the enterprise assistant, the coding agent and an interface for internal tools. Note: The official page returns 403 to fetching and the event was confirmed through a search summary; a further related announcement's date was not retrieved source The most recent sourced event, not a claim that nothing changed since. |
| Status | Active · Launch and a product update within 12 months |
| Openness | Code: Closed Weights: Closed No public weights and access is controlled; the companion life-sciences plugin sits in a public repository |
| Benchmarks reported | 1 counted (modified protocol 1, unconfirmed 5) |
| Wet-lab validation | None recorded |
| Unverified fields | † latest_update, training_data.a_public, training_data.b_private_licensed, training_data.c_own_wetlab_for_training, benchmarks_reported, other_evaluations |
| As of | 2026-11-16 |
What it does
A reasoning model for biology, drug discovery and translational medicine, used to weigh evidence, propose hypotheses, design experiments and carry out multi-step research tasks, with a companion plugin reaching more than fifty public multi-omics databases, literature sources and biology tools at inference time. Unlike open agents such as Biomni and Kosmos it is a base model behind controlled access, and unlike frontier general models it has undergone life-sciences post-training by undisclosed means.
Benchmarks reported
Every row is one pairing from the survey's relation file; a score belongs to the benchmark page's ranking, where it is shown with metric, eval set, source type and date. 1 of 6 pairings are counted.
| Benchmark | Relation | Eval set / protocol | Source type | Note and evidence |
|---|---|---|---|---|
| 18 LAB-Bench / LABBench2 | Developer report, modified protocol | — | Self-reported | 11 of 15 LABBench2 tasks, qualitative only. †partly verified · evidence |
| 14 PubMedQA | Unconfirmed (not counted) | — | Unconfirmed source | No report found †disputed · no source link |
| 23 BioASQ | Unconfirmed (not counted) | — | Unconfirmed source | No report was found. †disputed · no source link |
| 29 BixBench | Unconfirmed (not counted) | — | Unconfirmed source | Version unspecified and the numbers appear only in second-hand reports †disputed · evidence |
| 41 BioML-bench | Unconfirmed (not counted) | — | Unconfirmed source | No report found; the only evidence is a site page, so it is shown as unconfirmed. †disputed · no source link |
| 42 BioMysteryBench | Unconfirmed (not counted) | — | Unconfirmed source | No report found; the only evidence is a site page, so it is shown as unconfirmed. †disputed · no source link |
Other evaluations (outside the 44)
- Developer's own life-sciences evaluation (Own task set) Self-reported: 750 expert-written tasks with rubrics designed by outside experts and scored against them by another model from the same organisation
- Internal capability evaluations (Comparison against baselines only) Self-reported: Compared with the organisation's earlier models across chemistry, protein understanding, phylogenetics, experiment design and tool use, reported only second-hand
- Absent from the official boards (Public benchmark not among the 44) Third-party: Neither of the two relevant official boards lists it, so the self-reported figures cannot be checked against them
Developers report: the first life-sciences-specific reasoning model, leading among models with public scores on one bioinformatics analysis evaluation and beating their own previous model on part of a lab-protocol evaluation, with the clearest gain on molecular cloning questions.
Independent evidence: No independent evidence found. Neither relevant official board lists it and no third-party evaluation was found
Training data
Group in Figure 7: Not disclosed.
| Class | Value | Detail |
|---|---|---|
| a. Public databases | Not disclosed | The databases the plugin reaches are inference-time tools, not training data source |
| b. Private or licensed data | Not disclosed | |
| c. Own wet-lab data used for training | Not disclosed | |
| d. Wet lab used only for validation | No | No public wet-lab validation; partners describe only applying or assessing it in their own workflows |
Wet-lab validation
None. The developers report no wet-lab validation.
Background
- Organization: The developer is an AI lab and company based in San Francisco; this is the first model in its life-sciences line.
- Funding: On 31 March 2026 it announced a $122B round at an $852B post-money valuation, led by three companies with existing shareholders continuing; the split is not officially disclosed.
- Products and partnerships: Launch partners include two biopharmaceutical companies, a non-profit institute and a laboratory instruments company, with another pharmaceutical company added in a June 2026 update; earlier collaborations involved two pharmaceutical companies and an AI drug development company.
- Related models: Biomni, Kosmos / Edison Analysis, Co-Scientist, Frontier general-purpose LLMs
Reading notes
- Both evaluations were run by the developer with version, prompts and tool settings undisclosed, and neither official board lists it, so nothing can be compared with board scores.
- The official text is qualitative and the figures appear only in second-hand reports that contradict each other, so they must be treated as second-hand.
- It leads on only part of the protocol evaluation, which reads as strength in one kind of protocol design rather than an across-the-board lead.
- Controlled access makes outside reproduction hard, and the in-house evaluation is scored by another model from the same organisation, so judge and subject share a source.
Caveats
- Neither weights nor training data are public and there is no system card.
- The official page returns 403 to fetching, so several points could be checked only via cache or search summaries.
- Four benchmark pairings rest on this site's own pages and must display as unconfirmed.
- There is no public wet-lab validation; partners describe only use within their own workflows.
- The in-house evaluation's scorer and the model under test come from the same organisation.
Sources
- Developer launch announcement (company blog)
- Developer update announcement (company blog)
- Media report (second-hand) (second-hand) second-hand
- Developer help page (official site)
Corrections
None recorded.
Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-16.